Login / Signup

T-lymphocyte depleted transplants for inborn errors of immunity.

M A SlatterM A MaschanAndrew R Gennery
Published in: Expert review of clinical immunology (2023)
Pharmacokinetic monitoring of serotherapy agents, and use of co-stimulatory molecule blockade are likely to become more widespread. Post-transplant cyclophosphamide or TCR depletion strategies are likely to become the dominant methods of transplantation for nonmalignant diseases.
Keyphrases
  • regulatory t cells
  • low dose
  • high dose
  • peripheral blood
  • patient safety
  • adverse drug
  • cell therapy
  • emergency department
  • mesenchymal stem cells